James E. Pilling
AstraZeneca R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An image-based screen for secreted proteins involved in breast cancer G0 cell cycle arrest.
Journal: Scientific data
Published: February 16, 2024
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancer.
Journal: Communications biology
Published: January 27, 2023
A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
Journal: SLAS discovery : advancing life sciences R & D
Published: June 02, 2020
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.
Journal: Molecular cancer therapeutics
Published: June 28, 2018
Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 08, 2017
From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: January 11, 2017
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles.
Journal: Molecular cancer therapeutics
Published: September 09, 2016
Immunofluorescence microscopy of SNAP23 in human skeletal muscle reveals colocalization with plasma membrane, lipid droplets, and mitochondria.
Journal: Physiological reports
Published: January 07, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026